Renaissance Capital logo

VTYX News

US IPO Weekly Recap: Portillo’s gains 87% in an 11 IPO week

PTLO

The fall IPO market kept a brisk pace this past week with 11 IPOs, led by restaurant chain Portillo’s (PTLO). SPACs also stayed active, with 18 blank check IPOs. There was one postponement: winery Winc (WBEV). New filers continue to...read more

Inflammatory disease biotech Ventyx Biosciences prices upsized IPO at $16 midpoint

Ventyx Biosciences logo

Ventyx Biosciences, a Phase 1 biotech developing selective therapies for inflammatory and autoimmune diseases, raised $152 million by offering 9.5 million shares at $16, within the range of $15 to $17. The company offered 1.7 million more shares than anticipated...read more

US IPO Week Ahead: Consumer issuers remain active as hot dogs headline an 11 IPO week

PTLO

Updated Monday, 10/18. 11 IPOs are slated to raise $2.0 billion led by restaurant chain Portillo’s (PTLO). The diverse group also features investment management software, water pipelines, coconut water, and crypto mining. ...read more

Inflammatory disease biotech Ventyx Biosciences sets terms for $125 million IPO

Ventyx Biosciences logo

Ventyx Biosciences, a Phase 1 biotech developing selective therapies for inflammatory and autoimmune diseases, announced terms for its IPO on Friday. The Encinitas, CA-based company plans to raise $125 million by offering 7.8 million shares at a price range of...read more